Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
Statistics in Medicine · 2026-06 · 45 (13-14)
DOI: 10.1002/sim.70599 ↗At a glance
Journal article in Statistics in Medicine, published online on 2026-05-26. Written by Xi Fang and 5 co-authors. Institution: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. Major MEDLINE topics: Randomized Controlled Trials as Topic, Models, Statistical. 47 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, NIA NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (original language)
Progressive multi‐state survival outcomes are common in trials with recurrent or sequential events and require treatment effect estimands that remain interpretable without proportional intensity or Markov assumptions. The restricted mean time in favor of treatment (RMT‐IF) extends the restricted mean survival time to ordered multi‐state processes and provides such an interpretable estimand. However, existing RMT‐IF methods are nonparametric, assume covariate‐independent censoring for independent observations, and do not accommodate cluster‐randomized trials (CRTs), limiting both efficiency and applicability. We develop a class of doubly robust estimators for RMT‐IF under right censoring using an augmented inverse‐probability weighting framework that combines stage‐specific outcome regression with arm‐specific censoring models, yielding consistency when either nuisance model is correctly specified. We further extend the framework to CRTs by formalizing both cluster‐level and individual‐level average RMT‐IF estimands to address informative cluster size and by constructing corresponding doubly robust estimators that account for within‐cluster correlation. For inference, we employ model‐agnostic jackknife variance estimators in both individually randomized and cluster‐randomized settings. Extensive simulation studies demonstrate finite‐sample performance, and the methods are illustrated using two randomized trial examples.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
- Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, Connecticut, USA.
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA.
ORCID profiles: Xi Fang, Guangyu Tong, Shuangge Ma, Fan Li
Funding
- NHLBI NIH HHS
- NIA NIH HHS
- National Heart, Lung, and Blood Institute
Cite
APA
Fang, X., Wang, B., Tong, G., Hu, L., Ma, S., & Li, F. (2026). Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials. Statistics in Medicine, 45(13-14). https://doi.org/10.1002/sim.70599
Vancouver
Fang X, Wang B, Tong G, Hu L, Ma S, Li F. Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials. Statistics in Medicine. 2026;45(13-14). doi:10.1002/sim.70599
BibTeX
@article{Fang2026,
author = {Fang, Xi and Wang, Bingkai and Tong, Guangyu and Hu, Liangyuan and Ma, Shuangge and Li, Fan},
title = {Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials},
journal = {Statistics in Medicine},
year = {2026},
volume = {45},
number = {13-14},
doi = {10.1002/sim.70599}
}
EUVIMED